VIMTALABSNSEVimta Labs Limited· PharmaceuticalsLowNeutral
Announced Mon, 9 Mar · 17:01 IST

Vimta Labs Limited has informed the Exchange regarding allotment of 34166 securities pursuant to ESOP/ESPS at its meeting held on March 09, 2026

Capital Market Events View source PDF

VIMTALABS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Vimta Labs has allotted 34,166 equity shares to eligible employees under the Vimta Labs Employee Stock Option Plan 2021 at its ESOP Allotment Committee meeting held on March 9, 2026. The exercise price is ₹2 per share, which is the face value, meaning no premium was charged. As a result, the company's paid-up share capital increased from ₹8,92,70,378 (4,46,35,189 shares) to ₹8,93,38,710 (4,46,69,355 shares). The newly allotted shares will rank equally with existing shares and are not subject to any lock-in period. The company is completing listing formalities for the new shares.

Likely market impact

This is a routine ESOP allotment causing negligible dilution (about 0.008% increase in total share count) and is unlikely to have any material impact on the stock price. It reflects the company granting employee stock benefits as per its approved ESOP plan.